Exact Mass: 388.2726

Exact Mass Matches: 388.2726

Found 23 metabolites which its exact mass value is equals to given mass value 388.2726, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

MG(18:1(12Z)-2OH(9,10)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C21H40O6 (388.2825)


MG(18:1(12Z)-2OH(9,10)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/18:1(12Z)-2OH(9,10)/0:0)

1,3-Dihydroxypropan-2-yl (9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C21H40O6 (388.2825)


MG(0:0/18:1(12Z)-2OH(9,10)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

1-O-acetyl-2-O-[(R)-3-hydroxyhexadecanoyl]-sn-glycerol

1-O-acetyl-2-O-[(R)-3-hydroxyhexadecanoyl]-sn-glycerol

C21H40O6 (388.2825)


   

Dimethyl-10-methoxy-9-hydroxy-octadecan-1,18-dioat

Dimethyl-10-methoxy-9-hydroxy-octadecan-1,18-dioat

C21H40O6 (388.2825)


   

o-Hydroxyfinasteride

o-Hydroxyfinasteride

C23H36N2O3 (388.2726)


   

ascr#26

14R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-pentadecanoic acid

C21H40O6 (388.2825)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (14R)-14-hydroxypentadecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

oscr#26

15-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-pentadecanoic acid

C21H40O6 (388.2825)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 15-hydroxypentadecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

1-Bromodocosane

1-Bromodocosane

C22H45Br (388.2704)


   

azepan-2-one,hexanedioic acid,2-piperazin-1-ylethanamine

azepan-2-one,hexanedioic acid,2-piperazin-1-ylethanamine

C18H36N4O5 (388.2686)


   

TRANS-1-(4-PENTYLCYCLOHEXYL)-4-(2-(4-PROPOXYPHENYL)ETHYNYL)BENZENE

TRANS-1-(4-PENTYLCYCLOHEXYL)-4-(2-(4-PROPOXYPHENYL)ETHYNYL)BENZENE

C28H36O (388.2766)


   

11-(Bromomethyl)henicosane

11-(Bromomethyl)henicosane

C22H45Br (388.2704)


   

(14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadecanoic acid

(14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadecanoic acid

C21H40O6 (388.2825)


   

15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadecanoic acid

15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadecanoic acid

C21H40O6 (388.2825)


   

MG(18:1(12Z)-2OH(9,10)/0:0/0:0)

MG(18:1(12Z)-2OH(9,10)/0:0/0:0)

C21H40O6 (388.2825)


   

MG(0:0/18:1(12Z)-2OH(9,10)/0:0)

MG(0:0/18:1(12Z)-2OH(9,10)/0:0)

C21H40O6 (388.2825)


   

[3-Carboxy-2-(12-carboxydodecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(12-carboxydodecanoyloxy)propyl]-trimethylazanium

C20H38NO6+ (388.2699)


   

Finasteride 2-(2-Methylpropanol)amide

Finasteride 2-(2-Methylpropanol)amide

C23H36N2O3 (388.2726)


   

[(2R)-3-carboxy-2-(12-carboxydodecanoyloxy)propyl]-trimethylazanium

[(2R)-3-carboxy-2-(12-carboxydodecanoyloxy)propyl]-trimethylazanium

C20H38NO6+ (388.2699)


   

17alpha-Hydroxyprogesterone 3,20-bis(O-methyloxime)

17alpha-Hydroxyprogesterone 3,20-bis(O-methyloxime)

C23H36N2O3 (388.2726)


   

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C20H38NO6+ (388.2699)


   

ST 28:7;O

ST 28:7;O

C28H36O (388.2766)


   

(5r)-1-methoxy-1-oxodecan-5-yl (3r,5r)-3,5-dihydroxydecanoate

(5r)-1-methoxy-1-oxodecan-5-yl (3r,5r)-3,5-dihydroxydecanoate

C21H40O6 (388.2825)


   

1-methoxy-1-oxodecan-5-yl 3,5-dihydroxydecanoate

1-methoxy-1-oxodecan-5-yl 3,5-dihydroxydecanoate

C21H40O6 (388.2825)